FIPRUSI Trademark

Trademark Overview


On Monday, January 13, 2020, a trademark application was filed for FIPRUSI with the United States Patent and Trademark Office. The USPTO has given the FIPRUSI trademark a serial number of 79279552. The federal status of this trademark filing is REGISTERED as of Tuesday, July 7, 2020. This trademark is owned by Glaxo Group Limited. The FIPRUSI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
fiprusi

General Information


Serial Number79279552
Word MarkFIPRUSI
Filing DateMonday, January 13, 2020
Status700 - REGISTERED
Status DateTuesday, July 7, 2020
Registration Number6093307
Registration DateTuesday, July 7, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 2, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Friday, July 28, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, October 2, 2020NOTIFICATION PROCESSED BY IB
Saturday, September 12, 2020FINAL DISPOSITION NOTICE SENT TO IB
Saturday, September 12, 2020FINAL DISPOSITION PROCESSED
Thursday, August 6, 2020GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, July 7, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, April 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2020NOTICE OF PUBLICATION
Monday, March 16, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, March 15, 2020ASSIGNED TO EXAMINER
Friday, March 6, 2020APPLICATION FILING RECEIPT MAILED
Monday, March 2, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 29, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, February 27, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB